134 related articles for article (PubMed ID: 35402279)
1. The Therapeutic Effects of DDP/CD44-shRNA Nanoliposomes in AMF on Ovarian Cancer.
Guo T; Zhu Y; Yue M; Wang F; Li Z; Lin M
Front Oncol; 2022; 12():811783. PubMed ID: 35402279
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic effect and MR molecular imaging of FA-PEG-FePt/DDP nanoliposomes in AMF on ovarian cancer.
Bian X; Guo T; Chen G; Nie D; Yue M; Zhu Y; Lin M
Int J Nanomedicine; 2024; 19():5227-5243. PubMed ID: 38855734
[TBL] [Abstract][Full Text] [Related]
3. Use of S2.2/DOX Magnetic Nanoliposomes in MR Molecule Imaging and Targeted Thermochemotherapy for Breast Cancer In Vitro.
Zhu Y; Yang D; Guo T; Lin M
Technol Cancer Res Treat; 2023; 22():15330338231194498. PubMed ID: 37563954
[TBL] [Abstract][Full Text] [Related]
4. Using thermal energy produced by irradiation of Mn-Zn ferrite magnetic nanoparticles (MZF-NPs) for heat-inducible gene expression.
Tang QS; Zhang DS; Cong XM; Wan ML; Jin LQ
Biomaterials; 2008 Jun; 29(17):2673-9. PubMed ID: 18396332
[TBL] [Abstract][Full Text] [Related]
5. Enhancing Targeted Cancer Treatment by Combining Hyperthermia and Radiotherapy Using Mn-Zn Ferrite Magnetic Nanoparticles.
Wang Y; Zou L; Qiang Z; Jiang J; Zhu Z; Ren J
ACS Biomater Sci Eng; 2020 Jun; 6(6):3550-3562. PubMed ID: 33463170
[TBL] [Abstract][Full Text] [Related]
6. Ovarian carcinoma biological nanotherapy: Comparison of the advantages and drawbacks of lipid, polymeric, and hybrid nanoparticles for cisplatin delivery.
Zhang Y; Zhang P; Zhu T
Biomed Pharmacother; 2019 Jan; 109():475-483. PubMed ID: 30399584
[TBL] [Abstract][Full Text] [Related]
7. Hyperthermia evaluation and drug/protein-controlled release using alternating magnetic field stimuli-responsive Mn-Zn ferrite composite particles.
Montha W; Maneeprakorn W; Tang IM; Pon-On W
RSC Adv; 2020 Nov; 10(66):40206-40214. PubMed ID: 35520877
[TBL] [Abstract][Full Text] [Related]
8. LDR reverses DDP resistance in ovarian cancer cells by affecting ERCC-1, Bcl-2, Survivin and Caspase-3 expressions.
Ju X; Yu H; Liang D; Jiang T; Liu Y; Chen L; Dong Q; Liu X
Biomed Pharmacother; 2018 Jun; 102():549-554. PubMed ID: 29597088
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Manganese-Zinc Ferrite Nanoparticles as a Novel Magnetic Resonance Imaging Contrast Agent for the Detection of 4T1 Breast Cancer Cells.
Sobhani T; Shahbazi-Gahrouei D; Rostami M; Zahraei M; Farzadniya A
J Med Signals Sens; 2019; 9(4):245-251. PubMed ID: 31737553
[TBL] [Abstract][Full Text] [Related]
10. [Biological effect of down-regulating of MTRR gene on cisplatin-resistant ovarian cancer SKOV3 cells in vitro and in vivo studies].
Chen J; Wang Q; Zhang W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2016 Feb; 51(2):126-34. PubMed ID: 26917482
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD40 ligands sensitize the epithelial ovarian cancer cells to cisplatin treatment.
Qin L; Qiu H; Zhang M; Zhang F; Yang H; Yang L; Jia L; Qin K; Jia L; Dou X; Cheng L; Sang M; Zhang C; Shan B; Zhang Z
Biomed Pharmacother; 2016 Apr; 79():166-75. PubMed ID: 27044825
[TBL] [Abstract][Full Text] [Related]
12. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways.
Shen W; Liang B; Yin J; Li X; Cheng J
Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462
[TBL] [Abstract][Full Text] [Related]
13. [Effect of XPG down-regulation gene expression towards the proliferation of epithelial ovarian cancer cells and its chemosensitivity to platinum].
Zhang W; Wu FX; Wang Q; Li L
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):286-91. PubMed ID: 22781116
[TBL] [Abstract][Full Text] [Related]
14. Efficient inhibition of lung cancer in murine model by plasmid-encoding VEGF short hairpin RNA in combination with low-dose DDP.
Ma YP; Yang Y; Zhang S; Chen X; Zhang N; Wang W; Cao ZX; Jiang Y; Zhao X; Wei YQ; Deng HX
J Exp Clin Cancer Res; 2010 May; 29(1):56. PubMed ID: 20497582
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of MACC1 expression increases cisplatin sensitivity in cisplatin-resistant epithelial ovarian cancer cells.
Zhang R; Shi H; Ren F; Li X; Zhang M; Feng W; Jia Y
Oncol Rep; 2016 Apr; 35(4):2466-72. PubMed ID: 26794135
[TBL] [Abstract][Full Text] [Related]
16. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model.
Zhao H; Wei W; Sun Y; Gao J; Wang Q; Zheng J
DNA Cell Biol; 2015 Jan; 34(1):55-62. PubMed ID: 25211326
[TBL] [Abstract][Full Text] [Related]
17. Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells.
Liu L; Fan J; Ai G; Liu J; Luo N; Li C; Cheng Z
Biol Res; 2019 Jul; 52(1):37. PubMed ID: 31319879
[TBL] [Abstract][Full Text] [Related]
18. Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance in cisplatin-resistant ovarian carcinoma cell line.
Du P; Zhang X; Liu H; Chen L
DNA Cell Biol; 2015 Jul; 34(7):497-502. PubMed ID: 25941922
[TBL] [Abstract][Full Text] [Related]
19. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G
Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490
[TBL] [Abstract][Full Text] [Related]
20. FSTL1 increases cisplatin sensitivity in epithelial ovarian cancer cells by inhibition of NF-κB pathway.
Liu YK; Jia YJ; Liu SH; Ma J
Cancer Chemother Pharmacol; 2021 Mar; 87(3):405-414. PubMed ID: 33392640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
